Novartis
NVS
#55
Rank
A$384.05 B
Marketcap
A$200.15
Share price
-0.96%
Change (1 day)
31.13%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Earnings for Novartis (NVS)

Earnings in 2025 (TTM): A$25.57 Billion

According to Novartis's latest financial reports the company's current earnings are A$56.37 Billion. In 2024 the company made an earning of A$20.61 Billion, an increase over its 2023 earnings that were of A$13.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novartis from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$25.57 B24.07%
2024 A$20.61 B49.51%
2023 A$13.78 B13.48%
2022 A$12.15 B-69.24%
2021 A$39.50 B164.6%
2020 A$14.92 B10.49%
2019 A$13.51 B-36.26%
2018 A$21.19 B55.86%
2017 A$13.60 B15.12%
2016 A$11.81 B-3.9%
2015 A$12.29 B-33.72%
2014 A$18.54 B14.87%
2013 A$16.14 B-2.93%
2012 A$16.63 B2.15%
2011 A$16.28 B-7.94%
2010 A$17.68 B17.94%
2009 A$14.99 B4.45%
2008 A$14.35 B27.5%
2007 A$11.25 B-6.31%
2006 A$12.01 B9.46%
2005 A$10.98 B5.17%
2004 A$10.44 B13.84%
2003 A$9.17 B-38.51%
2002 A$14.91 B574.04%
2001 A$2.21 B83%
2000 A$1.20 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
A$34.89 B 40.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.91 B-27.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.96 B 97.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.75 B-44.57%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
A$14.09 B-43.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$2.67 B-89.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bristol-Myers Squibb
BMY
A$12.14 B-51.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$12.29 B-50.44%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.78 B-20.28%๐Ÿ‡ฌ๐Ÿ‡ง UK